Advertisement

SEDET Trial: Is Noninvasive Evaluation Sufficient to Identify Patients at High Risk of Arrhythmia?

  • M. Santini
  • R. Ricci
  • M. Zoni Berisso
Conference paper

Abstract

The superior effectiveness of implantable cardioverter-defibrillator (ICD) therapy as compared to pharmacological therapy in survivors of ventricular fibrillation (VF) and poorly tolerated ventricular tachycardia (VT) was proven by the prematurely terminated Amiodarone Versus Implantable Defibrillator (AVID) study which showed that patients randomized to ICD treatment had a much lower mortality (38% reduction after 1 year, and 25% reduction after 2 and 3 years) than patients randomized to amiodarone treatment [1].

Keywords

Heart Rate Variability Acute Myocardial Infarction Ventricular Tachycardia Thrombolytic Therapy Premature Ventricular Complex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The AVID investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 337:1576–1583CrossRefGoogle Scholar
  2. 2.
    Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JK, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, for the Multicenter Automatic Defibrillator Implantation Trial Investigators (1996) Improved survival with an implanted defibrillator in patients with prior myocardial infarction, low ejection fraction and asymptomatic non-sustained ventricular tachycardia. N Engl J Med 335:1933–1940PubMedCrossRefGoogle Scholar
  3. 3.
    Reikvam A, Ketley D (1997) Thrombolytic eligibility in acute myocardial infarction patients admitted to Norwegian hospitals. Int J Cardiol 61:79–83PubMedCrossRefGoogle Scholar
  4. 4.
    Juliard JM, Himbert D, Golmard JM, Aubry P, Karillon GJ, Boccara A, Benamer H, Steg PG (1997) Can we provide reperfusion therapy to all unselected patients admitted with acute myocardial infarction? J Am Coll Cardiol 30:157–164PubMedCrossRefGoogle Scholar
  5. 5.
    European Secondary Prevention Study Group (1996) Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 347:1203–1207Google Scholar
  6. 6.
    Pedretti RF, Laporta A, Etro MD, Gementi A, Bonelli R, Anza C, Colombo E, Maslowsky F, Santoro F, Carù B (1992) Influence of thrombolysis on signal-averaged electrocardiogram and late arrhythmic events after acute myocardial infarction. Am J Cardiol 69:866–872PubMedCrossRefGoogle Scholar
  7. 7.
    Pedretti RF, Colombo E, Sarzi Braga S, Carù B (1994) Effect of thrombolysis on heart rate variability and life-threatening ventricular arrhythmias in survivors of acute myocardial infarction. J Am Coll Cardiol 23:19–26PubMedCrossRefGoogle Scholar
  8. 8.
    Sager PT, Perlmutter RA, Rosenfeld LE, McPherson CA, Wackers FJ, Batsford WP (1988) Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. J Am Coll Cardiol 12:19–24PubMedCrossRefGoogle Scholar
  9. 9.
    French JK, Williams BF, Hart HH, Wyatt S, Poole JE, Ingram C, Ellis CJ, Williams MG, White HD (1996) Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. Br Med J 312:1637–1641CrossRefGoogle Scholar
  10. 10.
    Ozbek C, Heisel A, Krause M, Berg G, Hammer B, Bay W, Sen S, Schieffer H (1995) Comparison of mortality from acute myocardial infarction in patients receiving anistreplase with those not receiving thrombolysls. Am J Cardiol 76:1103–1107PubMedCrossRefGoogle Scholar
  11. 11.
    Behar S, Gottlieb S, Hod H, Benari B, Narinski R, Pauzner H, Rechavia E, Faibel HE, Katz A, Roth A, Goldhammer E, Freedberg NA, Rougin N, Kracoff O, Shapira C, Jafari J, Lotan C, Daka F, Weiss T, Kanetti M, Klutstein M, Rudnik L, Barasch E, Mahul N, Blondheim D (1996) The outcome of patients with acute myocardial infarction ineligible for thrombolytic therapy. Israeli Thrombolytic Survey Group. Am J Med 101:184–191Google Scholar
  12. 12.
    GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673–682CrossRefGoogle Scholar
  13. 13.
    Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR (1990) Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Lancet 335:1175–1178Google Scholar
  14. 14.
    Moss AJ, Davis HT, De Camilla J, Bayer LW (1979) Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction. Circulation 60:998–1003PubMedCrossRefGoogle Scholar
  15. 15.
    Bigger JT jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM (1984) The relationship among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation 69:250–258PubMedCrossRefGoogle Scholar
  16. 16.
    Julian DG, Boissel JP, de Bono DP, Fox K, Genomi M, Heikkila J, Lopez-Bescos L, Neuhaus KL, Schroder R, Sleight P, Specchia G, Swedberg K, Turina M, Verheugt FWA, Van de Werf F, Zijlstra F (1996) Task force of the ESC. Management of acute myocardial infarction. Eur Heart J 17:43–63Google Scholar

Copyright information

© Springer-Verlag Italia 2000

Authors and Affiliations

  • M. Santini
    • 1
  • R. Ricci
    • 1
  • M. Zoni Berisso
    • 2
  1. 1.Dipartimento di CardiologiaOspedale San Filippo NeriRomeItaly
  2. 2.Dipartimento di CardiologiaOspedale GallieraGenoaItaly

Personalised recommendations